UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 368

Sortiert nach

Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease

Journal of neurochemistry, 2012-02, Vol.120 (3), p.419-429

2012

Volltextzugriff (PDF)

Oxidative stress and mitochondrial dysfunction in Alzheimer's disease

Biochimica et biophysica acta, 2014-08, Vol.1842 (8), p.1240-1247

2014

Volltextzugriff (PDF)

Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance

Journal of neurochemistry, 2014-01, Vol.128 (1), p.162-172

2014

Volltextzugriff (PDF)

Consequences of RNA oxidation on protein synthesis rate and fidelity: implications for the pathophysiology of neuropsychiatric disorders

Biochemical Society transactions, 2017-10, Vol.45 (5), p.1053

2017

Volltextzugriff (PDF)

The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations

Lancet neurology, 2011-03, Vol.10 (3), p.275-279

2011

Volltextzugriff (PDF)

Alzheimer disease, the two-hit hypothesis: An update

Biochimica et biophysica acta, 2007-04, Vol.1772 (4), p.494-502

2007

Volltextzugriff (PDF)

Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex

Molecular neurodegeneration, 2018-02, Vol.13 (1), p.5-5, Article 5

2018

Volltextzugriff (PDF)

Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells

Neuroscience letters, 2010-01, Vol.468 (3), p.267-271

2010

Volltextzugriff (PDF)

Adiponectin-mimetic novel nonapeptide rescues aberrant neuronal metabolic-associated memory deficits in Alzheimer's disease

Molecular neurodegeneration, 2021-04, Vol.16 (1), p.23-23, Article 23

2021

Volltextzugriff (PDF)

The sterol regulatory element‐binding protein 2 is dysregulated by tau alterations in Alzheimer disease

Brain pathology (Zurich, Switzerland), 2019-07, Vol.29 (4), p.530-543

2019

Volltextzugriff (PDF)

Individual Case Analysis of Postmortem Interval Time on Brain Tissue Preservation

PloS one, 2016-03, Vol.11 (3), p.e0151615-e0151615

2016

Volltextzugriff (PDF)

Editorial: Insights in neuroenergetics, nutrition and brain health: 2023

Frontiers in neuroscience, 2023-12, Vol.17, p.1331872-1331872

2023

Volltextzugriff (PDF)

Gclc deficiency in mouse CNS causes mitochondrial damage and neurodegeneration

Human molecular genetics, 2017-04, Vol.26 (7), p.1376-1390

2017

Volltextzugriff (PDF)

Oxidative Damage to RNA in Aging and Neurodegenerative Disorders

Neurotoxicity research, 2012-10, Vol.22 (3), p.231-248

2012

Volltextzugriff (PDF)

Down‐regulation of serum gonadotropins but not estrogen replacement improves cognition in aged‐ovariectomized 3xTg AD female mice

Journal of neurochemistry, 2014-07, Vol.130 (1), p.115-125

2014

Volltextzugriff (PDF)

The Earliest Stage of Cognitive Impairment in Transition From Normal Aging to Alzheimer Disease Is Marked by Prominent RNA Oxidation in Vulnerable Neurons

Journal of neuropathology and experimental neurology, 2012-03, Vol.71 (3), p.233-241

2012

Volltextzugriff (PDF)

Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer's disease

Journal of neurochemistry, 2010-06, Vol.113 (5), p.1221-1229

2010

Volltextzugriff (PDF)

The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's Disease

Nutrition research (New York, N.Y.), 2016-12, Vol.36 (12), p.1305-1315

2016

Volltextzugriff (PDF)

SRPK2 phosphorylates tau and mediates the cognitive defects in Alzheimer's disease

The Journal of neuroscience, 2012-11, Vol.32 (48), p.17262-17272

2012

Volltextzugriff (PDF)

Early induction of oxidative stress in mouse model of Alzheimer disease with reduced mitochondrial superoxide dismutase activity

PloS one, 2012-01, Vol.7 (1), p.e28033-e28033

2012

Volltextzugriff (PDF)

Down-regulation of serum gonadotropins is as effective as estrogen replacement at improving menopause-associated cognitive deficits

Journal of neurochemistry, 2010-02, Vol.112 (4), p.870-881

2010

Volltextzugriff (PDF)

Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models

Journal of cell science, 2016-05, Vol.129 (9), p.1815-1830

2016

Volltextzugriff (PDF)

Intraneuronal amyloid β accumulation and oxidative damage to nucleic acids in Alzheimer disease

Neurobiology of disease, 2010-03, Vol.37 (3), p.731-737

2010

Volltextzugriff (PDF)

Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death

Molecular biology of the cell, 2011-05, Vol.22 (9), p.1452-1462

2011

Volltextzugriff (PDF)

Current approaches in the treatment of Alzheimer's disease

Biomedicine & pharmacotherapy, 2008-04, Vol.62 (4), p.199-207

2008

Volltextzugriff (PDF)

1 – 25 von 368

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(316)
Mit Volltextzugriff
(335)

Publikationsform

Sprache

Englisch
(344)
Japanisch
(49)
Koreanisch
(24)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease

Oxidative stress and mitochondrial dysfunction in Alzheimer's disease

Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance

Consequences of RNA oxidation on protein synthesis rate and fidelity: implications for the pathophysiology of neuropsychiatric disorders

The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations

Alzheimer disease, the two-hit hypothesis: An update

Mfn2 ablation causes an oxidative stress response and eventual neuronal death in the hippocampus and cortex

Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells

Adiponectin-mimetic novel nonapeptide rescues aberrant neuronal metabolic-associated memory deficits in Alzheimer's disease

The sterol regulatory element‐binding protein 2 is dysregulated by tau alterations in Alzheimer disease

Individual Case Analysis of Postmortem Interval Time on Brain Tissue Preservation

Editorial: Insights in neuroenergetics, nutrition and brain health: 2023

Gclc deficiency in mouse CNS causes mitochondrial damage and neurodegeneration

Oxidative Damage to RNA in Aging and Neurodegenerative Disorders

Down‐regulation of serum gonadotropins but not estrogen replacement improves cognition in aged‐ovariectomized 3xTg AD female mice

The Earliest Stage of Cognitive Impairment in Transition From Normal Aging to Alzheimer Disease Is Marked by Prominent RNA Oxidation in Vulnerable Neurons

Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer's disease

The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's Disease

SRPK2 phosphorylates tau and mediates the cognitive defects in Alzheimer's disease

Early induction of oxidative stress in mouse model of Alzheimer disease with reduced mitochondrial superoxide dismutase activity

Down-regulation of serum gonadotropins is as effective as estrogen replacement at improving menopause-associated cognitive deficits

Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models

Intraneuronal amyloid β accumulation and oxidative damage to nucleic acids in Alzheimer disease

Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death

Current approaches in the treatment of Alzheimer's disease

Suchergebnisse filtern